| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9364725 | Annales de Pathologie | 2005 | 8 Pages |
Abstract
Anti-TdT antibody represents a useful marker for differentiating lymphoma/acute lymphoblastic leukemia from other lymphomas. This marker, available in routine diagnosis should be systematically included in the panel of antibodies used for immunophenotyping hematologic malignancies.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Séverine Valmary, Marie Danjoux, Georges Delsol, Pierre Brousset,